{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:17:59Z","timestamp":1777976279530,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"DOI":"10.7759\/cureus.108285","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:59:58Z","timestamp":1777975198000},"source":"Crossref","is-referenced-by-count":0,"title":["Biventricular Heart Failure With Reduced Ejection Fraction in a Young Male: A Case Report"],"prefix":"10.7759","author":[{"given":"Chirag","family":"Lodha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.01.052","article-title":"Prescription of potentially harmful drugs in young adults with heart failure and reduced ejection fraction","volume":"123","author":"Alvarez PA","year":"2019","unstructured":"Alvarez PA, Truong CN, Briasoulis A, Ganduglia-Cazaban C. Prescription of potentially harmful drugs in young adults with heart failure and reduced ejection fraction. Am J Cardiol. 2019, 123:1458-63. 10.1016\/j.amjcard.2019.01.052","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1577680","article-title":"Cardiac contractility modulation to enhance optimized medical therapy and improve cardiac remodeling in advanced heart failure: a case report","volume":"12","author":"Feng L","year":"2025","unstructured":"Feng L, Su L, Ren J. Cardiac contractility modulation to enhance optimized medical therapy and improve cardiac remodeling in advanced heart failure: a case report. Front Cardiovasc Med. 2025, 12:1577680. 10.3389\/fcvm.2025.1577680","journal-title":"Front Cardiovasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2012.01.020","article-title":"Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support","volume":"18","author":"Goldstein DJ","year":"2012","unstructured":"Goldstein DJ, Maybaum S, MacGillivray TE, Moore SA, Bogaev R, Farrar DJ, Frazier OH. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. J Card Fail. 2012, 18:392-5. 10.1016\/j.cardfail.2012.01.020","journal-title":"J Card Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.11.023","article-title":"Severe heart failure and treatment with dapagliflozin across the ejection fraction spectrum: DAPA-HF and DELIVER","volume":"13","author":"Inciardi RM","year":"2025","unstructured":"Inciardi RM, Lu H, Claggett BL, et al.. Severe heart failure and treatment with dapagliflozin across the ejection fraction spectrum: DAPA-HF and DELIVER. JACC Heart Fail. 2025, 13:618-27. 10.1016\/j.jchf.2024.11.023","journal-title":"JACC Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v17.i6.107102","article-title":"Impact of optimal medical therapy in heart failure certification for hospitalists on guideline-directed medical therapy utilization","volume":"17","author":"Ishaq F","year":"2025","unstructured":"Ishaq F, Nguyen DT, Graviss EA, Ebunlomo E, Bhimaraj A, Fida N. Impact of optimal medical therapy in heart failure certification for hospitalists on guideline-directed medical therapy utilization. World J Cardiol. 2025, 17:107102. 10.4330\/wjc.v17.i6.107102","journal-title":"World J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1773","article-title":"Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial","volume":"22","author":"Karason K","year":"2020","unstructured":"Karason K, Lund LH, Dal\u00e9n M, et al.. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial. Eur J Heart Fail. 2020, 22:739-50. 10.1002\/ejhf.1773","journal-title":"Eur J Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2025.10.008","article-title":"Rationale, design, and baseline characteristics of the polypill for heart failure with reduced ejection fraction (POLY-HF) trial","author":"Keshvani N","year":"2025","unstructured":"Keshvani N, Rizvi SK, Khashami F, et al.. Rationale, design, and baseline characteristics of the polypill for heart failure with reduced ejection fraction (POLY-HF) trial. J Card Fail. 2025, 10.1016\/j.cardfail.2025.10.008","journal-title":"J Card Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2025.01","article-title":"Device-based strategies for monitoring congestion and guideline-directed therapy in heart failure: the who, when and how of personalised care","volume":"11","author":"Laborante R","year":"2025","unstructured":"Laborante R, Restivo A, Mele D, et al.. Device-based strategies for monitoring congestion and guideline-directed therapy in heart failure: the who, when and how of personalised care. Card Fail Rev. 2025, 11:e11. 10.15420\/cfr.2025.01","journal-title":"Card Fail Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.125.013074","article-title":"Network meta-analysis of quality of life in heart failure with reduced ejection fraction","volume":"18","author":"Margaryan R","year":"2025","unstructured":"Margaryan R, Sepehrvand N, Ouwerkerk W, Tromp J, Turgeon RD, Ezekowitz JA. Network meta-analysis of quality of life in heart failure with reduced ejection fraction. Circ Heart Fail. 2025, 18:e013074. 10.1161\/CIRCHEARTFAILURE.125.013074","journal-title":"Circ Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.10.298","article-title":"Care in heart failure clinic staffed by advanced practice providers is associated with higher prescription rates for guideline-directed medical therapy","volume":"30","author":"Menchaca JT","year":"2024","unstructured":"Menchaca JT, Toneu FA, Campbell M, Crumbs T, Osabutey A, Okoh A, Ogunniyi M. Care in heart failure clinic staffed by advanced practice providers is associated with higher prescription rates for guideline-directed medical therapy. J Card Fail. 2024, 30:242. 10.1016\/j.cardfail.2023.10.298","journal-title":"J Card Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/circ.147.suppl_1.P398","article-title":"Abstract P398: Using human-centered design methodology to identify challenges and inform the development of a digital toolkit to optimize heart failure guideline-directed medical therapy from diverse clinician, patient, and patient health partner perspectives","volume":"147","author":"Spaulding E","year":"2023","unstructured":"Spaulding E, Isakadze N, Molello N, et al.. Abstract P398: Using human-centered design methodology to identify challenges and inform the development of a digital toolkit to optimize heart failure guideline-directed medical therapy from diverse clinician, patient, and patient health partner perspectives. Circulation. 2023, 147:10.1161\/circ.147.suppl_1.P398","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001532","article-title":"The impact of midodrine on guideline-directed medical therapy in patients admitted with systolic heart failure","volume":"83","author":"Scoma CB","year":"2024","unstructured":"Scoma CB, Lee DH, Money D, Eichelberger G, Usmani A, Cohen AJ, Fernandez J. The impact of midodrine on guideline-directed medical therapy in patients admitted with systolic heart failure. J Cardiovasc Pharmacol. 2024, 83:353-8. 10.1097\/FJC.0000000000001532","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2378","article-title":"Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction","volume":"23","author":"Seferovi\u0107 PM","year":"2021","unstructured":"Seferovi\u0107 PM, Polovina M, Adlbrecht C, et al.. Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. Eur J Heart Fail. 2021, 23:1999-2007. 10.1002\/ejhf.2378","journal-title":"Eur J Heart Fail"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.524124","article-title":"Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes","volume":"112","author":"Simon MA","year":"2005","unstructured":"Simon MA, Kormos RL, Murali S, et al.. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005, 112:I32-6. 10.1161\/CIRCULATIONAHA.104.524124","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3618","article-title":"Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC","volume":"27","author":"Skouri H","year":"2025","unstructured":"Skouri H, Girerd N, Monzo L, et al.. Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2025, 27:707-22. 10.1002\/ejhf.3618","journal-title":"Eur J Heart Fail"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf784.1355","article-title":"Comparative analysis of outcomes: heart transplantation vs. left ventricular assist device therapy","volume":"46","author":"Sokolski M","year":"2025","unstructured":"Sokolski M, Ptak J, Krupka D, et al.. Comparative analysis of outcomes: heart transplantation vs. left ventricular assist device therapy. Eur Heart J. 2025, 46:10.1093\/eurheartj\/ehaf784.1355","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/483257-biventricular-heart-failure-with-reduced-ejection-fraction-in-a-young-male-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:59:58Z","timestamp":1777975198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/483257-biventricular-heart-failure-with-reduced-ejection-fraction-in-a-young-male-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.108285","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}